Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs
ISKANDAR PUTERI: Johor is set to become Asia’s largest insulin hub as India’s leading biotechnology…
The post Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs appeared first on The Independent Singapore News – Latest Breaking News